BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23821207)

  • 1. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity.
    Skalova A
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S30-6. PubMed ID: 23821207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
    Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
    Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.
    Pinto A; Nosé V; Rojas C; Fan YS; Gomez-Fernandez C
    Mod Pathol; 2014 Jan; 27(1):30-7. PubMed ID: 23807775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
    Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
    Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.
    Kawahara A; Taira T; Abe H; Takase Y; Kurita T; Sadashima E; Hattori S; Imamura I; Matsumoto S; Fujisaki H; Sueyoshi K; Akiba J; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):603-11. PubMed ID: 26252941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.
    Baghai F; Yazdani F; Etebarian A; Garajei A; Skalova A
    Pathol Res Pract; 2017 Sep; 213(9):1112-1118. PubMed ID: 28781197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands].
    Zhang XP; Ni H; Wang X; Chen H; Shi SS; Yu B; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):34-37. PubMed ID: 28072974
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F; Lacroix-Triki M; Serrano E; Vergez S; Barres BH; Meilleroux J; Delisle MB; Uro-Coste E
    J Oral Pathol Med; 2015 Apr; 44(4):244-51. PubMed ID: 25040635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathologic features of mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista DA; Westra WH; Ali SZ
    Cancer Cytopathol; 2013 May; 121(5):228-33. PubMed ID: 23042752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.
    Griffith CC; Stelow EB; Saqi A; Khalbuss WE; Schneider F; Chiosea SI; Seethala RR
    Cancer Cytopathol; 2013 May; 121(5):234-41. PubMed ID: 23225548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
    Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
    Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary Analog Secretory Carcinoma (MASC) Involving the Thyroid Gland: A Report of the First 3 Cases.
    Dettloff J; Seethala RR; Stevens TM; Brandwein-Gensler M; Centeno BA; Otto K; Bridge JA; Bishop JA; Leon ME
    Head Neck Pathol; 2017 Jun; 11(2):124-130. PubMed ID: 27400918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary Analogue Secretory Carcinoma.
    Parekh V; Stevens TM
    Arch Pathol Lab Med; 2016 Sep; 140(9):997-1001. PubMed ID: 27575269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
    Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
    Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma.
    Said-Al-Naief N; Carlos R; Vance GH; Miller C; Edwards PC
    Int J Surg Pathol; 2017 Apr; 25(2):127-140. PubMed ID: 27670353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A challenging diagnosis of mammary analogue secretory carcinoma (MASC) on fine needle aspiration cytology and cell block: A cytopathologist's perspective.
    Saraf P; Bharti JN; Malik A
    Cytopathology; 2023 Jul; 34(4):377-380. PubMed ID: 36825352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.